ID
41567
Description
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Pharmacogenetic Research Consent, Saliva Sample Collection) is to be filled out during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Keywords
Versions (1)
- 11/11/20 11/11/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 11, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
Description
Pharmacogenetic research consent
Description
Informed consent for pharmacogenetic research
Data type
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Description
Date informed consent for pharmacogenetics obtained
Data type
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Description
Saliva collection for pharmacogenetic research
Data type
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
Description
Date Saliva Sample for pharmacogenetic research was collected
Data type
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
- UMLS CUI [1,3]
- C0011008
Description
Reason for not obtaining informed consent for pharmacogenetic research
Data type
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2347500
- UMLS CUI [1,4]
- C1882120
Description
Other reason for not obtaining informed consent for pharmacogenetic research
Data type
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C1882120
- UMLS CUI [1,4]
- C0205394
- UMLS CUI [1,5]
- C0566251
Description
[hidden] This item will be calculated by InForm
Data type
text
Alias
- UMLS CUI [1]
- C2347029
Similar models
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0455046 (UMLS CUI [1,2])
C0455046 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C1882120 (UMLS CUI [1,4])
C2347500 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,5])